STOCK TITAN

Intuitive Collaborates with Deion “Coach Prime” Sanders to Raise Patient Awareness of Surgical Options

(Neutral)
(Neutral)
Tags
partnership

Intuitive (NASDAQ: ISRG) announced a collaboration with Deion “Coach Prime” Sanders to raise patient and caregiver awareness of surgical options, including robotic-assisted surgery with da Vinci systems. Sanders, who underwent da Vinci robotic surgery for bladder cancer in 2025 after consulting his physician, will share his personal decision-making experience to encourage patients to ask questions and engage in informed discussions with doctors.

According to Intuitive, more than 20 million patients have had surgery using da Vinci systems, which, when performed by trained surgeons, may enable more precise, less invasive procedures than open surgery and, depending on the procedure, may offer fewer complications, shorter recovery and less pain. The company highlights that da Vinci is a surgical tool, not a cancer treatment, outlines key surgical risks, and discloses that Sanders is compensated for his testimonial.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – ISRG

+5.73%
10 alerts
+5.73% Session close to close
+9.2% Peak in 24 hr 31 min
$126.97B Market Cap
0.6x Rel. Volume

In the Jul 27 session, ISRG gained 5.73%, reflecting a notable positive market reaction. Argus tracked a peak move of +9.2% during that session. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +5.7% in the session following this news. 7.16% was the 24-hour reaction to Intuitiv...
Analysis

The stock moved +5.7% in the session following this news. 7.16% was the 24-hour reaction to Intuitive's Q1 2026 earnings event, providing a positive historical comparator for this patient-awareness partnership. The platform also records Net Selling by insiders, a separate governance and sentiment risk to monitor.

Key Figures

Patients operated on: More than 20 million patients
1 metrics
Patients operated on More than 20 million patients Worldwide by surgeons using da Vinci systems

Historical Context

5 past events · Latest: Jul 23 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jul 23 AI healthcare vision Positive -2.5% AI-enabled surgical-care framework and telesurgery demonstration preceded a negative 24-hour reaction.
Jul 16 Second-quarter earnings Positive -14.2% Revenue growth, earnings, placements, and full-year guidance preceded a negative 24-hour reaction.
May 28 Leadership appointment Neutral +0.2% Taylor Patton became chief commercial and marketing officer with a successor transition.
May 21 Product innovations Positive -2.1% Da Vinci 5 ecosystem and Force Feedback enhancements preceded a negative 24-hour reaction.
Apr 21 First-quarter earnings Positive +7.2% Revenue, procedure growth, placements, cash, and guidance preceded a positive 24-hour reaction.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Three of five recent events diverged from their stated sentiment, while two were aligned, indicating varied market responses to company announcements.

Key Terms

robotic-assisted surgery, minimally invasive surgery, wristed instruments, perioperative outcomes
4 terms
robotic-assisted surgery medical
"including robotic-assisted surgery with da Vinci systems"
Robotic-assisted surgery uses a surgeon-controlled robotic system to perform or assist with operations, where the doctor operates instruments through small incisions while a machine translates their movements into precise actions. For investors, it matters because these systems change procedure costs, hospital purchasing and training needs, and recurring revenue from instruments and service contracts—similar to how a new industrial robot can reshape manufacturing costs and output.
minimally invasive surgery medical
"The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery"
Minimally invasive surgery uses small cuts, tiny instruments and often cameras to treat medical problems instead of large open operations, like fixing machinery through a keyhole rather than taking the whole machine apart. It matters to investors because these procedures typically reduce hospital stays, complications and recovery time, creating demand for specialized devices, training and outpatient services that can drive faster adoption, lower costs and recurring revenue streams for healthcare suppliers.
wristed instruments technical
"and wristed instruments (i.e., scissors, scalpels, and forceps)"
Wristed instruments are surgical tools whose tips have small, jointed articulations that move like a human wrist, giving surgeons more precise, multi-directional motion than straight, rigid instruments—think of a screwdriver with a tiny, flexible wrist at the tip. They matter to investors because adoption, pricing, and compatibility with surgical robots and hospital systems can drive recurring sales, aftermarket revenue, and influence a medical device maker’s growth prospects.
perioperative outcomes medical
"Comparing Perioperative Outcomes of Oncologic Minimally Invasive"
Perioperative outcomes are the measurable results and events that happen before, during, and after a surgical procedure, such as complications, infection rates, recovery time, length of hospital stay, readmissions, and mortality. They matter to investors because these outcomes influence the cost, demand, regulatory approval, reimbursement, and reputation associated with surgical products and services—similar to how a product’s quality and failure rate affect sales, warranty costs, and customer trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Collaboration aims to help patients feel more informed, prepared and engaged in their care

CoachPrime_PR5_Approved

SUNNYVALE, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced a collaboration with Deion “Coach Prime” Sanders to help increase patient awareness and understanding of surgical options, including robotic-assisted surgery with da Vinci systems.

Surgical decisions following a diagnosis are among the most complex, emotional, and time-sensitive that patients and their families face, yet independent research shows many patients struggle to find clear, trustworthy information about robotic-assisted surgery.1 This collaboration aims to increase patient and caregiver awareness and understanding of surgical options, supporting more informed conversations between patients and their physicians and, ultimately, more confident decision-making.

In 2025, after being diagnosed with bladder cancer, Coach Prime chose to undergo robotic surgery with da Vinci following discussions with his physician about his available options and the risks and benefits associated with each. His choice was based on what mattered most to him, including his recovery and returning to his daily life and responsibilities.

“When I was diagnosed, I learned quickly that you have choices when it comes to surgery, but not every patient knows to ask about them,” said Coach Prime. “I want to inspire others to talk with their doctors, ask questions, and understand what’s possible.”

CoachPrime_PR6_Approved

Coach Prime is now using his experience to help others facing health diagnoses and decisions better understand their options – encouraging patients to seek information, ask questions, and engage in informed discussions with their physicians about their care.

“Patients deserve to understand the surgical options available to them and how those options may align with what matters most in their lives,” said Jaime Wong, MD, Chief Medical Officer at Intuitive. “Hearing how others navigated similar decisions can help make complex choices feel more tangible and less overwhelming. When patients are informed, they have more meaningful conversations with their physicians and make decisions with greater confidence.”

More than 20 million patients worldwide have been operated on by surgeons using da Vinci systems.2 When performed by a trained surgeon, robotic-assisted surgery with da Vinci systems can help enable more precise and less invasive surgery, compared to open surgery, and depending on the procedure, may result in fewer complications, shorter recovery time and less pain.3

Additional Resources

  • Patients can learn more at davincisurgery.com.
  • Read more: Jaime Wong, MD, Chief Medical Officer at Intuitive, shares his perspective on patient empowerment and how patients can have meaningful conversations with their physicians about surgical options.

__________________________________
1
Jauniaux, B., Anand, A., Abbas, R., & Harji, D. P. (2025). From expectations to experiences: A systematic review of patient and public perspectives on robotic surgery. Journal of Robotic Surgery, 19(1), 484. https://doi.org/10.1007/s11701-025-02649-y
2 Intuitive data on file
3 Ricciardi R, et al. The COMPARE Study: Comparing Perioperative Outcomes of Oncologic Minimally Invasive Laparoscopic, da Vinci Robotic, and Open Procedures: A Systematic Review and Meta-analysis of the Evidence. Ann Surg. 2025;281(5):748-763.

About Intuitive
Intuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic-assisted surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most.

About da Vinci Surgical Systems
There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body. The da Vinci surgical system is a tool used for surgery; it does not treat cancer.

Important Safety Information
Patients should consult with their doctor to discuss both nonsurgical and surgical treatment options, including the benefits and risks associated with each. They should also ask whether surgery using the da Vinci system is appropriate for their specific situation. As with any surgical procedure, serious complications can occur, including, in rare cases, death. Potential risks include injury to tissues and organs, as well as the possibility of switching to alternative surgical techniques during the operation, which may result in longer operative times and increased risk of complications.

For a summary of the risks and considerations associated with surgery, please refer to intuitive.com/surgery.

Comments reflect an individual patient experience that may or may not be reproducible and are not generalizable. Patient outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics, and/or physician/surgeon experience. The da Vinci system is a tool used for surgery, but it does not treat cancer.

Coach Prime has received compensation from Intuitive for his testimonial.

@2026 Intuitive Surgical Operations, Inc. All rights reserved. Product and brand names/logos are trademarks or registered trademarks of Intuitive Surgical or their respective owner.

Forward-Looking Statements

This press release contains forward-looking statements which relate to expectations concerning matters that are not historical facts. Statements using words such as “estimates,” “projects,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “may,” “will,” “can,” “could,” “should,” “would,” “targeted,” “potential,” and similar words and expressions are intended to identify forward-looking statements. These forward-looking statements are necessarily estimates reflecting the judgment of Intuitive’s management and involve a number of risks and uncertainties that could cause actual results or impacts on its operations, financial performance, and business position to differ materially from those suggested by the forward-looking statements.

These forward-looking statements include, but are not limited to, statements related to research and development of products and services, manufacturing of products, integration of products, obtaining of regulatory approvals, technical and other performance of products and services, and making products and services available to more patients and health care professionals.

These forward-looking statements should be considered in light of various important factors and involve known and unknown risks, uncertainties, and other factors, which may cause the actual results, performance, or achievements of Intuitive, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements include, among others, economic conditions in the geographic markets in which we operate, changes in governmental regulations, regulatory approval priorities, resources, and timelines, regulatory enforcement priorities, governmental investigations and civil litigation, and other factors discussed in Intuitive’s Annual Reports and other filings with relevant securities regulators.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and which are based on current expectations and are subject to risks, uncertainties, and assumptions that are difficult to predict, including those risk factors identified under the heading “Risk Factors” in Intuitive’s Annual Report on Form 10-K for the year ended December 31, 2025, as updated by its other filings with the U.S. Securities and Exchange Commission. Intuitive’s actual results may differ materially and adversely from those expressed in any forward-looking statements, and it undertakes no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law.

Contact Information:
Media.inquiries@intusurg.com

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/f1f8aff8-5c63-4e66-aa9a-3e560202dc4e

https://www.globenewswire.com/NewsRoom/AttachmentNg/68b202d2-3e12-4620-81d9-88c23d7c6133


FAQ

What is the Intuitive (NASDAQ: ISRG) collaboration with Deion “Coach Prime” Sanders about?

The collaboration between Intuitive and Deion “Coach Prime” Sanders focuses on increasing patient awareness of surgical options, including robotic-assisted surgery. According to Intuitive, Sanders will share his personal surgical decision journey to encourage patients to ask questions and engage in informed discussions with their physicians about care choices.

How does Deion Sanders’ experience relate to da Vinci robotic surgery from Intuitive (ISRG)?

Deion Sanders chose robotic-assisted surgery with a da Vinci system for bladder cancer in 2025 after consulting his physician. According to Intuitive, he is using this experience to highlight that patients often have multiple surgical options and should actively discuss them with their doctors.

What does Intuitive (ISRG) say about the benefits of da Vinci robotic-assisted surgery?

Intuitive states that, when performed by trained surgeons, da Vinci robotic-assisted surgery can enable more precise, less invasive procedures than open surgery. According to Intuitive, depending on the procedure, this may result in fewer complications, shorter recovery times and less pain for patients.

Does the da Vinci surgical system from Intuitive (ISRG) treat cancer?

The da Vinci surgical system does not treat cancer; it is a surgical tool used by physicians. According to Intuitive, da Vinci provides high-definition 3D vision and robotic assistance to help surgeons perform minimally invasive procedures, but treatment decisions and outcomes depend on many clinical factors.

What safety information does Intuitive (ISRG) provide about da Vinci robotic surgery?

Intuitive advises patients to discuss both nonsurgical and surgical options, including risks and benefits, with their doctors. According to Intuitive, serious complications, including rare cases of death or organ injury, can occur with any surgery, and patients may need conversion to alternative surgical techniques during procedures.

Is Deion “Coach Prime” Sanders compensated for his work with Intuitive (NASDAQ: ISRG)?

Yes, Deion Sanders has received compensation from Intuitive for his testimonial and participation in this awareness effort. According to Intuitive, his comments reflect an individual patient experience that may not be reproducible or generalizable, as outcomes depend on patient, disease and physician-specific factors.